Eli Lilly And Co (NYSE:LLY) Shares Bought by Arthur M. Cohen & Associates LLC

Arthur M. Cohen & Associates LLC raised its holdings in Eli Lilly And Co (NYSE:LLY) by 2.8% during the third quarter, Holdings Channel reports. The institutional investor owned 48,180 shares of the company’s stock after buying an additional 1,307 shares during the period. Eli Lilly And Co makes up about 1.5% of Arthur M. Cohen & Associates LLC’s holdings, making the stock its 15th largest position. Arthur M. Cohen & Associates LLC’s holdings in Eli Lilly And Co were worth $5,388,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. raised its stake in Eli Lilly And Co by 0.8% in the second quarter. Vanguard Group Inc. now owns 71,134,378 shares of the company’s stock valued at $7,880,977,000 after buying an additional 578,045 shares in the last quarter. BlackRock Inc. raised its stake in Eli Lilly And Co by 1.5% in the second quarter. BlackRock Inc. now owns 61,979,145 shares of the company’s stock valued at $6,866,670,000 after buying an additional 898,845 shares in the last quarter. Northern Trust Corp raised its stake in Eli Lilly And Co by 0.3% in the second quarter. Northern Trust Corp now owns 11,056,098 shares of the company’s stock valued at $1,224,906,000 after buying an additional 32,421 shares in the last quarter. Nuveen Asset Management LLC raised its stake in Eli Lilly And Co by 20,030.9% in the second quarter. Nuveen Asset Management LLC now owns 7,265,844 shares of the company’s stock valued at $804,983,000 after buying an additional 7,229,751 shares in the last quarter. Finally, Amundi Pioneer Asset Management Inc. raised its stake in Eli Lilly And Co by 13.2% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 5,422,106 shares of the company’s stock valued at $600,715,000 after buying an additional 632,573 shares in the last quarter. Institutional investors own 77.22% of the company’s stock.

Shares of LLY stock opened at $113.53 on Friday. The stock’s 50-day moving average is $110.61 and its two-hundred day moving average is $112.67. The firm has a market cap of $106.81 billion, a price-to-earnings ratio of 20.46, a PEG ratio of 1.82 and a beta of 0.16. Eli Lilly And Co has a 1 year low of $101.36 and a 1 year high of $132.13. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.88 and a current ratio of 1.17.

Eli Lilly And Co (NYSE:LLY) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.43 by $0.05. The company had revenue of $5.48 billion for the quarter, compared to analyst estimates of $5.50 billion. Eli Lilly And Co had a return on equity of 107.99% and a net margin of 35.10%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the company posted $1.39 earnings per share. As a group, research analysts predict that Eli Lilly And Co will post 5.78 EPS for the current year.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 10th. Shareholders of record on Friday, November 15th will be issued a dividend of $0.645 per share. This represents a $2.58 annualized dividend and a dividend yield of 2.27%. The ex-dividend date is Thursday, November 14th. Eli Lilly And Co’s payout ratio is 46.49%.

In related news, CEO David A. Ricks purchased 4,615 shares of the stock in a transaction that occurred on Friday, October 25th. The shares were purchased at an average price of $108.38 per share, with a total value of $500,173.70. Following the completion of the acquisition, the chief executive officer now directly owns 157,405 shares in the company, valued at approximately $17,059,553.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Alfonso G. Zulueta sold 19,500 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $112.91, for a total value of $2,201,745.00. Following the transaction, the senior vice president now directly owns 38,306 shares in the company, valued at approximately $4,325,130.46. The disclosure for this sale can be found here. In the last ninety days, insiders have acquired 8,405 shares of company stock worth $909,004 and have sold 614,373 shares worth $70,546,895. Company insiders own 0.11% of the company’s stock.

A number of analysts have weighed in on LLY shares. UBS Group cut their price target on Eli Lilly And Co from $134.00 to $133.00 and set a “buy” rating on the stock in a research note on Thursday, October 17th. Bank of America initiated coverage on Eli Lilly And Co in a report on Wednesday, October 16th. They set a “buy” rating and a $133.00 price objective on the stock. Six research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Eli Lilly And Co presently has an average rating of “Buy” and a consensus target price of $130.03.

About Eli Lilly And Co

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions.

Further Reading: How much can an individual set aside as a catch-up contribution?

Want to see what other hedge funds are holding LLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly And Co (NYSE:LLY).

Institutional Ownership by Quarter for Eli Lilly And Co (NYSE:LLY)

Leave a Reply

Your email address will not be published. Required fields are marked *

*